In March 2025, the company announced new programs for a immediate-to-buyer presenting of its Wegovy weight loss drug. The company set up a different pharmacy, called NovoCare, which might cost customers $499 monthly for usage of the drug, under 50 percent the expense of the drug via other pharmaceutical distribution networks.[fifty three]Novo Nordi